BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31951761)

  • 1. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.
    Dastiridou A; Karathanou K; Riga P; Anagnostopoulou S; Balasubramanian S; Mataftsi A; Brazitikos P; Ziakas N; Androudi S
    Ocul Immunol Inflamm; 2021 Jul; 29(5):926-931. PubMed ID: 31951761
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study.
    Busch C; Wakabayashi T; Sato T; Fukushima Y; Hara C; Shiraki N; Winegarner A; Nishida K; Sakaguchi H; Nishida K
    Sci Rep; 2019 Feb; 9(1):1561. PubMed ID: 30733512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
    Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
    Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
    Moon BG; Um T; Lee J; Yoon YH
    Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
    Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
    Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
    JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
    Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
    Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
    Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.
    Chung EJ; Roh MI; Kwon OW; Koh HJ
    Retina; 2008; 28(7):957-63. PubMed ID: 18698297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.
    Lukic M; Williams G; Shalchi Z; Sim D; Patel PJ; Keane PA; Hykin PG; Sivaprasad S; Menon D; Bruynseels A; Hamilton RD; Rajendram R
    Eur J Ophthalmol; 2020 May; 30(3):557-562. PubMed ID: 30808179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
    Bressler NM; Beaulieu WT; Glassman AR; Blinder KJ; Bressler SB; Jampol LM; Melia M; Wells JA;
    JAMA Ophthalmol; 2018 Mar; 136(3):257-269. PubMed ID: 29392288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
    Cheong KX; Lee SY; Ang M; Teo KYC
    Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
    Lee J; Moon BG; Cho AR; Yoon YH
    Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
    AttaAllah HR; Mohamed AAM; Ali MA
    Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
    Korobelnik JF; Gaucher D; Baillif S; Creuzot-Garcher C; Kodjikian L; Weber M
    Ophthalmologica; 2023; 246(2):71-80. PubMed ID: 36646050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
    Ceylan A; Dogan ME; Demircan A; Akar Y
    Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
    Ghashut R; Muraoka Y; Ooto S; Iida Y; Miwa Y; Suzuma K; Murakami T; Kadomoto S; Tsujikawa A; Yoshimura N
    Retina; 2018 Aug; 38(8):1571-1580. PubMed ID: 28671896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.